Company: OCEA
Filing Date: 2025-04-08
Form Type: 10-K
Source: 0001641172-25-003155
Chunk: 2161

Company: Ocean Biomedical, Inc.
Filing Date: 2025-04-08
Form: 10-K
Item: Item 1A
Chunk 2161
---
 intend to take advantage of the benefits of this extended transition period.

We
will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) following the fifth anniversary of
the completion of our IPO (i.e., December 31, 2026), (b) in which we have total annual gross revenue of at least $1.07 billion, or (c)
in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates
exceeds $700 million as of the prior June 30th, and (2) the date on which we have issued more than $1.0 billion in non-convertible
debt securities during the prior three-year period.

Additionally,
we are a “smaller reporting company” as defined in Rule 10(f)(1) of Regulation S-K. Smaller reporting companies may take
advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements.
We will remain a smaller reporting company until the last day of the fiscal year in which (1) the market value of our common stock held
by non-affiliates equals or exceeds $250 million as of the end of the prior June 30th, or (2) our annual revenues equaled
or exceeded $100 million during such completed fiscal year and the market value of our common stock held by non-affiliates exceeds $700
million as of the prior June 30th.

Available
Information

We
file annual reports, quarterly reports, current reports, proxy statements and other information with the Securities and Exchange Commission
(the “SEC”). Our SEC filings are available to the public through the “Investors” portion of our website as soon
as practicable after we have electronically filed such material with, or furnished it to, the SEC. In addition, the SEC maintains a website
that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC
at www.sec.gov.

Our
internet address is www.oceanbiomedical.com. The information on our website is not, and shall not be deemed to be, part of this Annual
Report on Form 10-K or incorporated into any other filings we make with the SEC, except as shall be expressly set forth by specific reference
in any such filings. All website addresses in this report are intended to be inactive textual references only